Efficacy of VRx MyBiotics Oral Lozenges

Viome

Status

Completed

Conditions

Oral Microbiome Health

Treatments

Dietary Supplement: VRx MyBiotics Oral Lozenges

Study type

Interventional

Funder types

Industry

Identifiers

NCT05972330

V308

Details and patient eligibility

About

This study will test the efficacy of Viome's VRx MyBiotics Oral Lozenges at improving the oral microbiome.

Full description

This is a single arm, interventional trial on adults residing in the United States. The study will test the efficacy of personalized oral biotic lozenges (VRx MyBiotics Oral Lozenges) at improving oral microbiome health according to Viome's Oral Health Score.

Enrollment

34 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Any person with a US address that is 18 years old or older
Able to speak and read English
Willing and able to follow the trial instructions, as described in the recruitment letter
Signed and dated informed consent prior to any trial-specific procedures.

Exclusion criteria

Systemic antibiotic treatment 30 days prior to enrollment or during the trial
Not willing to stop sporadic use (less frequently than daily) of any mouthwash.
Significant diet, supplements, or lifestyle change in the previous 1 month or next 2 months once enrolled
Allergy to tapioca, peppermint, or sweet potato
Current diagnosis of periodontitis or other advanced oral disease (chronic recurrent caries, oral cancer, etc)
No dental procedures 30 days prior to enrollment or during the trial (regular cleanings, bone grafts, dental implants, etc)
Pregnancy or planned pregnancy
Currently have cancer or undergoing cancer therapy
Dentures
Fewer than 20 teeth
Use of at home teeth whitening products 30 days prior to enrollment or during the trial
Start new medications or supplements during the trial